OCT 24, 2017 7:00 AM PDT

WEBINAR: Biomarker Discovery: Metabolomics Differentiates Known Disease Classifications of Prostate Cancer

Sponsored by: SCIEX
Speaker

Abstract

DATE: October, 24, 2017
TIME:  7:00 AM PDT

 

Metabolomics focuses on the chemical processes central to cellular metabolism. A robust mass spectrometry solution for screening metabolites is of increased interest allowing for a more integrated and routine analysis. A new QTOF System was developed for routine, robust workflows which require minimal MS expertise. The system integrates all data acquisition, processing and review in a single software. A prostate cancer study was used to determine whether the untargeted metabolomics workflow using the X500R System could find key differences between the samples.


Urine samples were obtained with disease classifications, previously determined using accepted clinical techniques. Samples were extracted, dried and reconstituted in 50 µL of 0.1% formic acid in water. A standard reverse phase gradient was used employing mobile phase A as 0.1% formic acid in water and mobile phase B as acetonitrile. The data were collected using information dependent acquisition (IDA) on the X500R QTOF System (SCIEX). Data were processed in MarkerView™ Software 1.3 and PCA analysis was performed. Ions of interest were saved as an Interest List and copied into SCIEX OS Software where a formula was generated for each mz - RT ion pairs, these formulae were scored using MS and MS/MS data, and searched using databases.


In this study, samples from a pilot prostate cancer study were analyzed and a clear difference between healthy and disease urine samples was detected using this untargeted metabolomics approach, confirming the original disease classifications. MarkerView Software was used to determine a list of the statistically significant analytes that distinguished the samples, and then the SCIEX OS compound searching provided formulae finding as well as structural matching through ChemSpider database. Most changes were in the small molecule amino acids. This pilot study provided confidence in the approach, and the next larger phase of the study analyzing a much larger set of samples is underway.

 

Learning objectives:

  • Learn about the untargeted metabolomics workflow using the new X500R QTOF system
  • Learn how the X500R QTOF system allows the distinction between healthy and diseased cells
  • Learn about the streamlined data processing workflow for identifying and confirming biomarkers using database searches

Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
OCT 12, 2021 9:00 AM PDT
C.E. CREDITS
OCT 12, 2021 9:00 AM PDT
Date: October 12, 2021 Time: 9:00am (PDT), 12:00pm (EDT) SCIEX’s next-generation Biologics Explorer software is an innovative platform for the comprehensive and deep characterization o...
AUG 24, 2021 11:00 AM PDT
C.E. CREDITS
AUG 24, 2021 11:00 AM PDT
Date: August 24, 2021 Time: 11:00am (PDT), 1:00pm (EDT) Electron-based dissociation mechanisms have shown great promise for advanced characterization of biomolecules. However, routine adopti...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
DEC 09, 2021 6:00 AM PST
C.E. CREDITS
DEC 09, 2021 6:00 AM PST
Date: December 9, 2021 Time: 6:00am (PDT), 9:00 am (EDT) As the number of biotherapeutic candidates in development is increasing, the requirements of analytical tools to understand the molec...
OCT 24, 2017 7:00 AM PDT

WEBINAR: Biomarker Discovery: Metabolomics Differentiates Known Disease Classifications of Prostate Cancer

Sponsored by: SCIEX


Show Resources
Loading Comments...
Show Resources